Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
SALES $ 382,244 $ 405,417
COST OF SALES (excluding depreciation expense) 83,384 70,048
GROSS PROFIT 298,860 335,369
OPERATING EXPENSES:    
Compensation and related benefits (including stock-based compensation of $6,735,124 and $6,772,752 for the years ended December 31, 2018 and 2017, respectively) 7,823,381 7,852,965
Research and development 258,294 214,112
Professional fees 1,006,939 131,022
General and administrative expenses 478,348 428,953
Total Operating Expenses 9,566,962 8,627,052
LOSS FROM OPERATIONS (9,268,102) (8,291,683)
OTHER EXPENSES:    
Loss on debt extinguishment (383,475)
Settlement expense (200,000)
Interest expenses (53,142) (8,009)
Total Other Expenses (636,617) (8,009)
NET LOSS $ (9,904,719) $ (8,299,692)
NET LOSS PER COMMON SHARE:    
Basic and diluted $ (0.14) $ (0.18)
WEIGHTED AVERAGE COMMON SHARE OUTSTANDING:    
Basic and diluted 68,521,112 45,284,735